Santalum album cream - Santalis Healthcare
Alternative Names: Albuterpenoid; East Indian sandalwood oil; EISO; SAN 007; VIR 003; VIR 007Latest Information Update: 06 Jan 2023
At a glance
- Originator ViroXis
- Developer Santalis Healthcare Corporation; Santalis Pharmaceuticals
- Class Anti-infectives; Phytotherapies; Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Atopic dermatitis; Condylomata acuminata; Molluscum contagiosum
- No development reported Human papillomavirus infections; Poxvirus infections
Most Recent Events
- 06 Jan 2023 Discontinued - Phase-II for Atopic dermatitis (In adults) in USA (Topical)
- 18 Sep 2020 Phase II development in Condylomata acuminata still ongoing in the US (NCT03158974)
- 18 Sep 2020 No development reported - Phase-II for Atopic dermatitis (In adults) in USA (Topical)